Intec Pharma

$4.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-2.19%) Today
-$0.05 (-1.12%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Intec Pharma and other stocks, options, and ETFs commission-free!

About NTEC

Intec Pharma Ltd. Ordinary Shares, also called Intec Pharma, is a clinical-stage biopharmaceutical company engaging in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel. The listed name for NTEC is Intec Pharma Ltd. Ordinary Shares.

CEO
Jeffrey A. Meckler
Employees
49
Headquarters
Jerusalem, Jerusalem
Founded
2000
Market Cap
17.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.09M
High Today
$4.58
Low Today
$4.40
Open Price
$4.50
Volume
187.22K
52 Week High
$15.82
52 Week Low
$2.20

Collections

NTEC Earnings

-$0.95
-$0.63
-$0.32
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

MKC.V
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure